Subclinical hypothyroidism: A historical view and shifting prevalence

International Journal of Clinical Practice

Volumn 69, Issue 7, 2015, Pages 771-782

  Hennessey, J V ^a   Espaillat, R ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b ABBVIE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; INTERFERON; INTERLEUKIN DERIVATIVE; LITHIUM SALT; PROTEIN TYROSINE KINASE INHIBITOR; RADIOACTIVE IODINE; THYROID ANTIBODY; THYROTROPIN;

AFRICAN AMERICAN; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; CAUCASIAN; EXTERNAL BEAM RADIOTHERAPY; GEOGRAPHY; HUMAN; HYPOTHYROIDISM; MEXICAN AMERICAN; OBESITY; OVERT HYPOTHYROIDISM; PARTIAL THYROIDECTOMY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX; SUBCLINICAL HYPOTHYROIDISM; SUBTOTAL THYROIDECTOMY; SYSTEMATIC REVIEW; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; BLOOD; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HEALTH; REPRODUCIBILITY;

DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GLOBAL HEALTH; HUMANS; HYPOTHYROIDISM; PREVALENCE; REPRODUCIBILITY OF RESULTS; THYROTROPIN;

EID: 84933279412     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12619     Document Type: Review

References (68)

1. Garber JR, Cobin RH, Gharib H, et al., Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 2012; 22: 1200-35.
2. Razvi S, Shakoor A, Vanderpump M, et al., The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab 2008; 93: 2998-3007.
3. Asvold BO, Vatten LJ, Nilsen TI, Bjoro T,. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol 2007; 156: 181-6.
4. Chonchol M, Lippi G, Salvagno G, et al., Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1296-300.
5. Franklyn JA,. The thyroid-too much and too little across the ages. The consequences of subclinical thyroid dysfunction. Clin Endocrinol (Oxf) 2013; 78: 1-8.
6. Parle JV, Franklyn JA, Cross KW, et al., Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 1993; 43: 107-9.
7. Hennessey JV, Malabanan AO, Haugen BR, Levy EG,. Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the American Thyroid Association, American Association of Clinical Endocrinologists, and the Endocrine Society. Endocr Pract 2010; 16: 357-70.
8. Boelaert K, Syed AA, Manji N, et al., Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism. Clin Endocrinol (Oxf) 2009; 70: 129-38.
9. De Moraes AV, Pedro AB, Romaldini JH,. Spontaneous hypothyroidism in the follow up of Graves hyperthyroid patients treated with antithyroid drugs. South Med J 2006; 99: 1068-72.
10. Braverman LE, Cooper DS,. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 10th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2013.
11. Dietrich JW, Landgrafe G, Fotiadou EH,. TSH and thyrotropic agonists: key actors in thyroid homeostasis. J Thyroid Res 2012; 2012: 351864.
12. Wiersinga WM,. Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance. Neth J Med 1995; 46: 197-204.
13. Kim TH, Kim KW, Ahn HY, et al., Effect of seasonal changes on the transition between subclinical hypothyroid and euthyroid status. J Clin Endocrinol Metab 2013; 98: 3420-9.
14. Caron PJ, Nieman LK, Rose SR, Nisula BC,. Deficient nocturnal surge of thyrotropin in central hypothyroidism. J Clin Endocrinol Metab 1986; 62: 960-4.
15. Konno N, Taguchi H, Miura K, et al., Serum thyrotropin concentration in apparently healthy adults, in relation to urinary iodide concentration. Clin Chem 1993; 39: 174-5.
16. Wong ET, Bradley SG, Schultz AL,. Elevations of thyroid-stimulating hormone during acute nonthyroidal illness. Arch Intern Med 1981; 141: 873-5.
17. Konno N, Yuri K, Taguchi H, et al., Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin Endocrinol (Oxf) 1993; 38: 273-81.
18. Sawin CT, Chopra D, Azizi F, et al., The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA 1979; 242: 247-50.
19. Tunbridge WM, Evered DC, Hall R, et al., The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-93.
20. Riniker M, Tieche M, Lupi GA, et al., Prevalence of various degrees of hypothyroidism among patients of a general medical department. Clin Endocrinol (Oxf) 1981; 14: 69-74.
21. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC,. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-34.
22. Demers LM, Spencer CA,. Laboratory Medicine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. Washington, DC: National Academy of Clinical Biochemistry, 2002.
23. Hollowell JG, Staehling NW, Flanders WD, et al., Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-99.
24. Hamilton TE, Davis S, Onstad L, Kopecky KJ,. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab 2008; 93: 1224-30.
25. Asvold BO, Bjoro T, Vatten LJ,. Associations of TSH levels within the reference range with future blood pressure and lipid concentrations: 11-year follow-up of the HUNT study. Eur J Endocrinol 2013; 169: 73-82.
26. Surks MI, Hollowell JG,. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007; 92: 4575-82.
27. Sawin CT, Castelli WP, Hershman JM, et al., The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985; 145: 1386-8.
28. Boucai L, Hollowell JG, Surks MI,. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid 2011; 21: 5-11.
29. Nystrom E, Bengtsson C, Lindquist O, et al., Thyroid disease and high concentration of serum thyrotrophin in a population sample of women. A 4-year follow-up. Acta Med Scand 1981; 210: 39-46.
30. Falkenberg M, Kagedal B, Norr A,. Screening of an elderly female population for hypo- and hyperthyroidism by use of a thyroid hormone panel. Acta Med Scand 1983; 214: 361-5.
31. Brochmann H, Bjoro T, Gaarder PI, et al., Prevalence of thyroid dysfunction in elderly subjects. A randomized study in a Norwegian rural community (Naeroy). Acta Endocrinol (Copenh) 1988; 117: 7-12.
32. Drinka PJ, Nolten WE,. Prevalence of previously undiagnosed hypothyroidism in residents of a midwestern nursing home. South Med J 1990; 83: 1259-61, 65.
33. Bagchi N, Brown TR, Parish RF,. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med 1990; 150: 785-7.
34. Parle JV, Franklyn JA, Cross KW, et al., Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991; 34: 77-83.
35. Geul KW, van Sluisveld IL, Grobbee DE, et al., The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids. Clin Endocrinol (Oxf) 1993; 39: 275-80.
36. Volzke H, Ludemann J, Robinson DM, et al., The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003; 13: 803-10.
37. Hoogendoorn EH, Hermus AR, de Vegt F, et al., Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2006; 52: 104-11.
38. Bensenor IM, Goulart AC, Lotufo PA, et al., Prevalence of thyroid disorders among older people: results from the Sao Paulo Ageing & Health Study. Cad Saude Publica 2011; 27: 155-61.
39. Glinoer D,. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997; 18: 404-33.
40. Stagnaro-Green A, Abalovich M, Alexander E, et al., Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21: 1081-125.
41. Haddow JE, Knight GJ, Palomaki GE, et al., The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen 2004; 11: 170-4.
42. Soldin OP, Soldin D, Sastoque M,. Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide. Ther Drug Monit 2007; 29: 553-9.
43. Stricker R, Echenard M, Eberhart R, et al., Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol 2007; 157: 509-14.
44. Nyrnes A, Jorde R, Sundsfjord J,. Serum TSH is positively associated with BMI. Int J Obes 2006; 30: 100-5.
45. Bastemir M, Akin F, Alkis E, Kaptanoglu B,. Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Med Wkly 2007; 137: 431-4.
46. Knudsen N, Laurberg P, Rasmussen LB, et al., Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005; 90: 4019-24.
47. Kitahara CM, Platz EA, Ladenson PW, et al., Body fatness and markers of thyroid function among U.S. men and women. PLoS ONE 2012; 7: e34979.
48. Lips MA, Pijl H, van Klinken JB, et al., Roux-en-Y gastric bypass and calorie restriction induce comparable time-dependent effects on thyroid hormone function tests in obese female subjects. Eur J Endocrinol 2013; 169: 339-47.
49. Ruiz-Tovar J, Boix E, Galindo I, et al., Evolution of subclinical hypothyroidism and its relation with glucose and triglycerides levels in morbidly obese patients after undergoing sleeve gastrectomy as bariatric procedure. Obes Surg 2014; 24: 791-5.
50. Chikunguwo S, Brethauer S, Nirujogi V, et al., Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis 2007; 3: 631-5; discussion 5-6.
51. Mantzoros CS, Ozata M, Negrao AB, et al., Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab 2001; 86: 3284-91.
52. Rotondi M, Leporati P, La Manna A, et al., Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol 2009; 160: 403-8.
53. Rotondi M, Leporati P, Rizza MI, et al., Raised serum TSH in morbid-obese and non-obese patients: effect on the circulating lipid profile. Endocrine 2014; 45: 92-7.
54. Reinehr T,. Obesity and thyroid function. Mol Cell Endocrinol 2010; 316: 165-71.
55. Vanderpump MP, Tunbridge WM, French JM, et al., The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55-68.
56. Huber G, Staub JJ, Meier C, et al., Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 2002; 87: 3221-6.
57. Asvold BO, Vatten LJ, Midthjell K, Bjoro T,. Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT Study in Norway. J Clin Endocrinol Metab 2012; 97: 93-9.
58. Diez JJ, Iglesias P,. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab 2004; 89: 4890-7.
59. Gussekloo J, van Exel E, de Craen AJ, et al., Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004; 292: 2591-9.
60. Somwaru LL, Rariy CM, Arnold AM, Cappola AR,. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 2012; 97: 1962-9.
61. Meyerovitch J, Rotman-Pikielny P, Sherf M, et al., Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch Intern Med 2007; 167: 1533-8.
62. Surks MI, Ortiz E, Daniels GH, et al., Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-38.
63. Rosario PW, Bessa B, Valadao MM, Purisch S,. Natural history of mild subclinical hypothyroidism: prognostic value of ultrasound. Thyroid 2009; 19: 9-12.
64. Shin DY, Kim EK, Lee EJ,. Role of ultrasonography in outcome prediction in subclinical hypothyroid patients treated with levothyroxine. Endocr J 2010; 57: 15-22.
65. Lee MW, Shin DY, Kim KJ, et al., The biochemical prognostic factors of subclinical hypothyroidism. Endocrinol Metab (Seoul) 2014; 29: 154-62.
66. Razvi S, Weaver JU, Butler TJ, Pearce SH,. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med 2012; 172: 811-7.
67. Bremner AP, Feddema P, Leedman PJ, et al., Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 2012; 97: 1554-62.
68. Waring AC, Arnold AM, Newman AB, et al., Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab 2012; 97: 3944-50.